Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guaiazulene is a small molecule sesquiterpenoid derived from the guaiane skeleton, commonly found in chamomile oil and other natural sources. It is primarily used as a cosmetic color additive and in personal care products for its soothing properties[2][3][7]. In medicine, it has been formulated for ophthalmic use and topical applications due to its anti-inflammatory effects[2][7]. Guaiazulene exerts biological activity by stabilizing cell membrane structures, inhibiting cyclooxygenase‐2 (COX‐2), regulating cytokine secretion, and reducing histamine release from mast cells[6][8]. Derivatives of guaiazulene have shown potential anticancer activity through inhibition of mitochondrial electron transport complex II, leading to decreased oxidative phosphorylation and induction of apoptosis in cancer cells[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on guaiazulene.